Wettig Thane

Average Profitability
7.99%
Insider Buys Quantity
2
Insider Buys Sum
$131,213.00
Insider Sells Quantity
7
Insider Sells Sum
$365,022.61

Insider Activity of Wettig Thane

According to the SEC Form 4 filings, Wettig Thane, being in a position of

  1. CEO at FibroGen, Inc.,
    оver the last 12 months, has bought 50000 shares for $95,470, and sold 0 shares,
    over all time since 2021-08-26, has bought 53100 shares for $131,213, and sold 18504 shares for $365,023.

The largest purchase of all time was on 2024-03-07 and amounted to 50000 shares of FibroGen, Inc. for $95,470.

The largest sale of all time was on 2023-03-10 and amounted to 7669 shares of FibroGen, Inc. for $154,893.

Biography of Wettig Thane

No biography is available at this moment.

2024-03-07PurchaseFibroGen, Inc.
FGEN
CEO
50,000
0.0545%
$1.91$95,470-37.08%
2023-06-23SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
791
0.0009%
$16.53$13,075-92.77%
2023-06-07SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
1,758
0.0018%
$17.04$29,951-92.99%
2023-03-23SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
905
0.001%
$18.71$16,933-90.49%
2023-03-10SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
7,669
0.0081%
$20.20$154,893-91.15%
2023-03-08SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
6,265
0.0067%
$21.16$132,542-91.44%
2022-12-23SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
734
0.0008%
$15.80$11,597-82%
2022-12-08SaleFibroGen, Inc.
FGEN
Chief Commercial Officer
382
0.0004%
$15.79$6,032+1.43%
2021-08-26PurchaseFibroGen, Inc.
FGEN
Chief Commercial Officer
3,100
0.0034%
$11.53$35,743+7.99%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.